Literature DB >> 11734091

Quality of life with nonpharmacologic treatment of hypertension.

J P Roel1, C L Hildebrant, R H Grimm.   

Abstract

Therapeutic treatment of hypertension has been achieved successfully with both pharmacologic and nonpharmacologic interventions. Clinical trials have shown that various approaches to treatment result in different levels of blood pressure reduction as well as varying effects on quality of life. Standardizing the approach to measuring quality of life would be beneficial to the assessment of treatment outcomes in hypertension trials. This article reviews some of the strengths and weaknesses of both pharmacologic and nonpharmacologic treatments of hypertension, with special emphasis placed on effects of quality of life.

Entities:  

Mesh：

Year:  2001        PMID： 11734091     DOI： 10.1007/s11906-001-0008-8

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


  47 in total

1.  Effectiveness of a dietary intervention strategy in general practice: effects on blood lipids, health and well-being.

Authors:  U I Traeden; L Holm; B Sandström; P K Andersen; M Jarden
Journal:  Public Health Nutr       Date:  1998-12       Impact factor: 4.022

2.  Change in symptoms of hypertensive patients after referral to hospital clinic.

Authors:  C J Bulpitt; C T Dollery; S Carne
Journal:  Br Heart J       Date:  1976-02

3.  Effect of change in sodium excretion on change in blood pressure corrected for measurement error. The Trials of Hypertension Prevention, Phase I.

Authors:  N R Cook; S K Kumanyika; J A Cutler
Journal:  Am J Epidemiol       Date:  1998-09-01       Impact factor: 4.897

4.  Baseline correlates with quality of life among men and women with medication-controlled hypertension. The trial of nonpharmacologic interventions in the elderly (TONE).

Authors:  R T Anderson; P Hogan; L Appel; R Rosen; S A Shumaker
Journal:  J Am Geriatr Soc       Date:  1997-09       Impact factor: 5.562

5.  Comprehensive nutrition plan improves cardiovascular risk factors in essential hypertension.

Authors:  D A McCarron; S Oparil; L M Resnick; A Chait; R B Haynes; P Kris-Etherton; F X Pi-Sunyer; J S Stern; C D Morris; S Clark; D C Hatton; J A Metz; M McMahon; S Holcomb; G W Snyder
Journal:  Am J Hypertens       Date:  1998-01       Impact factor: 2.689

6.  Improved quality of life in patients with generalized cardiovascular metabolic disease on a prepared diet.

Authors:  D C Hatton; R B Haynes; S Oparil; P Kris-Etherton; F X Pi-Sunyer; L M Resnick; J S Stern; S Clark; M McMahon; C Morris; J Metz; A Ward; S Holcomb; D A McCarron
Journal:  Am J Clin Nutr       Date:  1996-12       Impact factor: 7.045

7.  Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial--the Hypertension Control Program.

Authors:  R Stamler; J Stamler; R Grimm; F C Gosch; P Elmer; A Dyer; R Berman; J Fishman; N Van Heel; J Civinelli
Journal:  JAMA       Date:  1987-03-20       Impact factor: 56.272

Review 8.  Blood pressure, systolic and diastolic, and cardiovascular risks. US population data.

Authors:  J Stamler; R Stamler; J D Neaton
Journal:  Arch Intern Med       Date:  1993-03-08

9.  Impairment of memory function by antihypertensive medication.

Authors:  S Solomon; E Hotchkiss; S M Saravay; C Bayer; P Ramsey; R S Blum
Journal:  Arch Gen Psychiatry       Date:  1983-10

10.  Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial.

Authors:  L J Appel; M Espeland; P K Whelton; T Dolecek; S Kumanyika; W B Applegate; W H Ettinger; J B Kostis; A C Wilson; C Lacy
Journal:  Ann Epidemiol       Date:  1995-03       Impact factor: 3.797
View more
  1 in total

1.  Omega-3 Fatty Acids Supplementation Differentially Modulates the SDF-1/CXCR-4 Cell Homing Axis in Hypertensive and Normotensive Rats.

Authors:  Luiza Halmenschlager; Alexandre Machado Lehnen; Aline Marcadenti; Melissa Medeiros Markoski
Journal:  Nutrients       Date:  2017-08-01       Impact factor: 5.717
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.